COVID-19-related myocarditis and cholinergic anti-inflammatory pathways

被引:5
作者
Liu, Weike [1 ,2 ]
Liu, Zhendong [3 ]
Li, Yue-Chun [1 ,2 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, Dept Cardiol, 109 Xueyuan Rd, Wenzhou 325000, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, 109 Xueyuan Rd, Wenzhou 325000, Zhejiang, Peoples R China
[3] Shandong First Med Univ, Basic Med Coll, 18877 Jingshi Rd, Jinan 250062, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Severe acute respiratory syndrome coronavirus-2; Myocarditis; Cholinergic anti-inflammatory pathway; VAGUS NERVE; CONVERTING ENZYME; INFLAMMATORY RESPONSE; VIRAL MYOCARDITIS; ACE2; COMORBIDITIES; PREVALENCE; MODULATION; PHYSIOLOGY; STRATEGY;
D O I
10.1016/j.hjc.2020.12.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2, is currently in a pandemic outbreak and has become a global health issue. In addition to the primarily involvement of the respiratory system, myocarditis is considered an important and fatal lesion in patients with COVID-19. However, effective therapeutic methods are currently lacking. The cholinergic anti-inflammatory pathway (CAP) has been demonstrated to suppress pro-inflammatory cytokine production and control inflammation in sepsis and other medical conditions. Therefore, the CAP may be a potential and effective therapeutic method for COVID-19-related myocarditis. This article reviews the relationship between COVID-19-related myocarditis and the CAP and discusses the CAP as a potential therapeutic modality in the treatment of COVID-19-related myocarditis. (C) 2020 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.
引用
收藏
页码:265 / 269
页数:5
相关论文
共 50 条
  • [21] Management of a critically ill patient with COVID-19-related fulminant myocarditis: A case report
    Shahrami, Bita
    Davoudi-Monfared, Effat
    Rezaie, Zahra
    Gheibi, Shayesteh
    Vakili-Ardabili, Ayda
    Arabzadeh, Amir Ahmad
    Talebi, Ali
    Mojtahedzadeh, Mojtaba
    RESPIRATORY MEDICINE CASE REPORTS, 2022, 36
  • [22] The role of the cholinergic anti-inflammatory pathway in septic cardiomyopathy
    Wang, Wenting
    Xu, Hui
    Lin, Huan
    Molnar, Megan
    Ren, Hongsheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 90
  • [23] The intestinal cholinergic anti-inflammatory pathway
    Goverse, Gera
    Stakenborg, Michelle
    Matteoli, Gianluca
    JOURNAL OF PHYSIOLOGY-LONDON, 2016, 594 (20): : 5771 - 5780
  • [24] Anti-inflammatory effects of eplerenone on viral myocarditis
    Xiao, Jie
    Shimada, Miho
    Liu, Wenling
    Hu, Dayi
    Matsumori, Akira
    EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (04) : 349 - 353
  • [25] Anti-inflammatory role of obestatin in autoimmune myocarditis
    Pamukcu, Ozge
    Baykan, Ali
    Bayram, Latife Cakir
    Narin, Figen
    Cetin, Nazmi
    Narin, Nazmi
    Argun, Mustafa
    Ozyurt, Abdullah
    Uzum, Kazim
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2016, 43 (01) : 47 - 55
  • [26] Consensus recommendations for COVID-19-related myocarditis in athletes: proof of concept-case report
    Abdelfattah, Omar M.
    Mathur, Tarun
    Martinez, Matthew W.
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2023, 7 (02)
  • [27] RIC3, the cholinergic anti-inflammatory pathway, and neuroinflammation
    Ben-David, Yael
    Kagan, Sara
    Ben-Ami, Hagit Cohen
    Rostami, Jinar
    Mizrahi, Tehila
    Kulkarni, Abhijit R.
    Thakur, Ganesh A.
    Vaknin-Dembinsky, Adi
    Healy, Luke M.
    Brenner, Talma
    Treinin, Millet
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 83
  • [28] Neuro-immune interactions in the cholinergic anti-inflammatory reflex
    Reardon, Colin
    IMMUNOLOGY LETTERS, 2016, 178 : 92 - 96
  • [29] The cholinergic anti-inflammatory pathway ameliorates acute viral myocarditis in mice by regulating CD4+ T cell differentiation
    Zhou De-Pu
    Ge Li-Sha
    Chen Guang-Yi
    Gu Xiaohong
    Xing Chao
    Zheng Cheng
    Zhang Wen-Wu
    Li Jia
    Lin Jia-Feng
    Chu Maoping
    Li Yue-Chun
    VIRULENCE, 2018, 9 (01) : 1364 - 1376
  • [30] Modulation of preeclampsia by the cholinergic anti-inflammatory pathway: Therapeutic perspectives
    Wedn, Abdalla M.
    El-Bassossy, Hany M.
    Eid, Ali H.
    El-Mas, Mahmoud M.
    BIOCHEMICAL PHARMACOLOGY, 2021, 192